Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Kaya Ltd - 539276 - Clarification On Increase/Spurt In Volume

 This is in response to NSE Letter bearing Ref. No. NSE/CM/Surveillance/10958 dated July 7, 2021 and BSE email bearing reference no. L/SURV/ONL/PV/RS/2021-2022/205 received on July 8,2021. Please note that in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, the Company has promptly intimated to the Exchanges of all events, information etc. that it believes may have a probable bearing on the operation / performance of the company including all potentially price sensitive information. There is no further undisclosed / potentially price sensitive information / event / announcement that the Company has not announced / declared to and / or requires an announcement to the Exchanges. Therefore, we would like to inform to your good office that the increase in volume of our scrip and in the share price is purely market driven / conditions and based on information available in public domain only.
08-07-2021
Bigul

Kaya Ltd - 539276 - Clarification sought from Kaya Ltd

 The Exchange has sought clarification from Kaya Ltd on July 8, 2021, with reference to Movement in Volume.The reply is awaited.
08-07-2021
Bigul

Kaya Ltd - 539276 - Submission Of Reconciliation Of Share Capital Audit Report For The Quarter Ended June 30, 2021

 With reference to the captioned subject, we enclose the Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2021 issued by M/s. Magia Halwai & Associates, Company Secretaries.
08-07-2021
Bigul

Kaya Ltd - 539276 - Intimation Under Regulation 30 Read With Schedule III Of SEBI (Listing Obligation And Disclosures Requirements) Regulations, 2015.

 We would like to inform you that Kaya Middle East DMCC ('DMCC') the wholly owned subsidiary of the Company, is transferring the business under Minal Medical Centre LLC, Sharjah, subsidiary of DMCC to an entity to be incorporated in Dubai under the name M M C Skin Care LLC, Dubai, (proposed name), which would also be a subsidiary of DMCC. This transfer of business is to counter the operational and regulatory challenges faced by the business in Sharjah. The relocation is within the radius of 10kms, however, in a different Emirate. The existing assets & liabilities of Minal Medical Centre, LLC Sharjah would be transferred to the new entity being incorporated in Dubai and shall be operated with the existing resources and equipment. The transfer would be completed in two parts, viz., a. Incorporation of M M C Skin Care LLC, Dubai (Annexure 'A') and b. Winding up of Minal Medical Centre LLC, Sharjah. (Annexure 'B')
08-06-2021
Bigul

Kaya Ltd - 539276 - Submission Of Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Please find attached disclosure on Related Party Transactions, on consolidated basis, in accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended March 31, 2021
07-06-2021
Bigul

Kaya Ltd - 539276 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the annual secretarial compliance report for the financial year ended March 31, 2021 received from M/s Magia Halwai & Associates, Company Secretaries, Mumbai
31-05-2021

Earnings Call for Q4FY21 of Kaya Ltd.

 Conference Call with Kaya Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.
20-05-2021
Bigul

Kaya Ltd - 539276 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Performance Update
19-05-2021
Bigul

Kaya Ltd - 539276 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed a media release by Kaya Limited for the quarter ended March 31, 2021. This is for your information and records.
19-05-2021
Bigul

Kaya Ltd - 539276 - Announcement under Regulation 30 (LODR)-Change in Directorate

 This is to inform you that the Board of Directors of Kaya Limited at its meeting held today i.e. Wednesday, May 19, 2021 has, interalia, a. approved the Standalone and Consolidated Audited Financial Results of the Company, for the quarter and financial year ended March 31, 2021; b. Appointed Mr. Rishabh Mariwala (DIN 03072284), (son of Mr. Harsh Mariwala, Chairman & Managing Director) as an Additional Non-Executive Director on Board, w.e.f. May 19, 2021; The appointment of Mr. Rishabh Mariwala shall be subject to the approval of the shareholders at the 18th Annual General Meeting. c. Accepted the resignation of Ms. Ameera Shah (DIN 00208095), Independent Director of the Company w.e.f. May 19, 2021. Further, the Company has received a confirmation from Ms. Ameera Shah that there are no material reasons for her resignation other than those mentioned in her resignation letter.
19-05-2021
Next Page
Close

Let's Open Free Demat Account